239 related articles for article (PubMed ID: 36064671)
21. Unmet needs in modern vaccinology: adjuvants to improve the immune response.
Leroux-Roels G
Vaccine; 2010 Aug; 28 Suppl 3():C25-36. PubMed ID: 20713254
[TBL] [Abstract][Full Text] [Related]
22. [Subunit vaccines--antigens, carriers, conjugation methods and the role of adjuvants].
Jarząb A; Skowicki M; Witkowska D
Postepy Hig Med Dosw (Online); 2013 Nov; 67():1128-43. PubMed ID: 24379254
[TBL] [Abstract][Full Text] [Related]
23. Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators.
Tandrup Schmidt S; Foged C; Korsholm KS; Rades T; Christensen D
Pharmaceutics; 2016 Mar; 8(1):. PubMed ID: 26978390
[TBL] [Abstract][Full Text] [Related]
24. Candidate vaccine antigens and genes in Pasteurella multocida.
Adler B; Bulach D; Chung J; Doughty S; Hunt M; Rajakumar K; Serrano M; van Zanden A; Zhang Y; Ruffolo C
J Biotechnol; 1999 Aug; 73(2-3):83-90. PubMed ID: 10486918
[TBL] [Abstract][Full Text] [Related]
25. Effects of Selected Adjuvants on Immunogenicity and Protectivity of
Ghadimipour R; Ghorbanpoor M; Gharibi D; Mayahi M; Jabbary AR
Arch Razi Inst; 2021 Oct; 76(4):741-749. PubMed ID: 35096310
[TBL] [Abstract][Full Text] [Related]
26. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.
Holmgren J; Adamsson J; Anjuère F; Clemens J; Czerkinsky C; Eriksson K; Flach CF; George-Chandy A; Harandi AM; Lebens M; Lehner T; Lindblad M; Nygren E; Raghavan S; Sanchez J; Stanford M; Sun JB; Svennerholm AM; Tengvall S
Immunol Lett; 2005 Mar; 97(2):181-8. PubMed ID: 15752556
[TBL] [Abstract][Full Text] [Related]
27. Recent advances of vaccine adjuvants for infectious diseases.
Lee S; Nguyen MT
Immune Netw; 2015 Apr; 15(2):51-7. PubMed ID: 25922593
[TBL] [Abstract][Full Text] [Related]
28. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
[TBL] [Abstract][Full Text] [Related]
29. Immune responses against chimeric DNA and protein vaccines composed of plpEN-OmpH and PlpEC-OmpH from Pasteurella multocida A:3 in mice.
Okay S; Ozcengiz E; Ozcengiz G
Acta Microbiol Immunol Hung; 2012 Dec; 59(4):485-98. PubMed ID: 23195557
[TBL] [Abstract][Full Text] [Related]
30. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
De Magistris MT
Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
[TBL] [Abstract][Full Text] [Related]
31. Gamma-Irradiated Fowl Cholera Mucosal Vaccine: Potential Vaccine Candidate for Safe and Effective Immunization of Chicken Against Fowl Cholera.
Dessalegn B; Bitew M; Asfaw D; Khojaly E; Ibrahim SM; Abayneh T; Gelaye E; Unger H; Wijewardana V
Front Immunol; 2021; 12():768820. PubMed ID: 34917086
[TBL] [Abstract][Full Text] [Related]
32.
Mostaan S; Ghasemzadeh A; Asadi Karam MR; Ehsani P; Sardari S; Shokrgozar MA; Abolhassani M; Nikbakht Brujeni G
Vector Borne Zoonotic Dis; 2021 Nov; 21(11):870-874. PubMed ID: 34788150
[No Abstract] [Full Text] [Related]
33. Adjuvants in perspective.
Vogel FR
Dev Biol Stand; 1998; 92():241-8. PubMed ID: 9554280
[TBL] [Abstract][Full Text] [Related]
34. Construction of a ptfA chitosan nanoparticle DNA vaccine against Pasteurella multocida and the immune response in chickens.
Gong Q; Kong LY; Niu MF; Qin CL; Yang Y; Li X; Ruan MD; Tian Y; Li ZL
Vet J; 2018 Jan; 231():1-7. PubMed ID: 29429481
[TBL] [Abstract][Full Text] [Related]
35. Innate endogenous adjuvants prime to desirable immune responses via mucosal routes.
Wang X; Meng D
Protein Cell; 2015 Mar; 6(3):170-84. PubMed ID: 25503634
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of two live Pasteurella multocida aro-A mutant vaccines in chickens.
Scott PC; Markham JF; Whithear KG
Avian Dis; 1999; 43(1):83-8. PubMed ID: 10216763
[TBL] [Abstract][Full Text] [Related]
37. Recent Developments in Vaccine Design: From Live Vaccines to Recombinant Toxin Vaccines.
Gupta S; Pellett S
Toxins (Basel); 2023 Sep; 15(9):. PubMed ID: 37755989
[TBL] [Abstract][Full Text] [Related]
38. Intranasal immunization with a non-adjuvanted adhesive protein descended from Pasteurella pneumotropica and its preventive efficacy against opportunistic infection in mice.
Sasaki H; Ishikawa H; Kojima K; Itoh M; Matsumoto T; Itoh T; Hosomi O; Kawamoto E
Vaccine; 2013 Nov; 31(48):5729-35. PubMed ID: 24091313
[TBL] [Abstract][Full Text] [Related]
39. Immunology of gut mucosal vaccines.
Pasetti MF; Simon JK; Sztein MB; Levine MM
Immunol Rev; 2011 Jan; 239(1):125-48. PubMed ID: 21198669
[TBL] [Abstract][Full Text] [Related]
40. Adjuvants and delivery issues related to immunization: a survey of the recent patent literature.
Mrsny RJ
J Drug Target; 1998; 6(4):243-9. PubMed ID: 9894692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
